AI reads MRIs to spot dangerous prostate cancers without a needle
NCT ID NCT06842264
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to develop and test an AI model that analyzes prostate MRI scans to predict whether a cancer is aggressive (clinically significant). Researchers will use data from 3,000 patients who had both an MRI and a biopsy. The goal is to create a tool that helps doctors decide who really needs a biopsy, reducing unnecessary procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate, non-invasive way to predict aggressive prostate cancer, potentially reducing the need for biopsies.
- What could go wrong
- This is an observational study using existing data, so it cannot prove the AI model works in real-time. The results may not apply to all patients or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University First Hospital
RECRUITINGBeijing, 100034, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?